Stoke Therapeutics reported cash from operations of -$56.59M and free cash flow of -$58.56M for the quarter ended Jun 2026, down 122.6% year over year. This cash flow statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||
| Net Income | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 112.88M | -23.48M | -38.35M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Share-based CompensationStock Comp. | 4.61M | 4.74M | 4.97M | 6.16M | 5.93M | 5.84M | 5.89M | 6.76M | 6.55M | 6.10M | 5.41M | 7.43M | 7.49M | 7.17M | 6.75M | 7.60M | 37.00M | 9.85M | 78.40M | 83.10M | |||||||||||||
| Deferred Taxes | |||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.70M | ||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -14.68M | -16.26M | 32.49M | -19.93M | -22.06M | -22.37M | -21.36M | -21.80M | -17.26M | -20.65M | -24.57M | -17.48M | -21.61M | -23.19M | 131.83M | -25.42M | -30.37M | -30.45M | -60.58M | -56.59M | |||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.30M | 1.32M | -5.08M | 11.33M | -3.31M | -1.49M | 2.73M | ||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 2.45M | 3.60M | -3.44M | 1.06M | -1.35M | 0.20M | 0.35M | -4.43M | 2.02M | -1.15M | -1.92M | 3.58M | -0.75M | 2.18M | 4.74M | 2.77M | 4.88M | 8.90M | -15.72M | 2.60M | |||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.27M | 0.27M | 0.84M | 0.68M | 2.03M | 0.41M | 0.55M | 0.46M | 0.38M | 0.23M | 0.01M | 0.05M | 0.10M | 0.04M | 0.15M | 0.15M | 0.13M | 0.23M | 0.35M | 1.98M | |||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | |||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 9.00M | 53.37M | 79.00M | 18.03M | 53.25M | 24.31M | 15.00M | 15.00M | 10.00M | 20.00M | 30.00M | 32.80M | 33.23M | 33.15M | 37.40M | 60.90M | 47.10M | ||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -5.26M | 11.80M | -135.78M | 0.15M | 67.26M | 22.49M | 53.09M | 23.47M | 14.62M | 14.77M | 9.99M | -88.28M | -30.00M | 0.82M | 13.63M | -148.48M | 9.09M | -61.06M | 50.69M | 9.02M | |||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.07M | 0.17M | 0.17M | 0.25M | 0.15M | 0.16M | 0.05M | 0.35M | 0.00M | 0.25M | 0.77M | 0.14M | 0.57M | 1.00M | 0.55M | 2.49M | 4.56M | 3.21M | 1.91M | ||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.41M | 0.17M | 42.51M | 3.42M | 0.43M | 0.04M | 45.05M | 0.05M | 0.56M | 7.34M | 1.72M | 120.65M | 8.16M | 0.57M | 1.37M | 0.55M | 3.12M | 92.34M | 84.33M | 1.91M | |||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.31M | 2.06M | 0.36M | 0.08M | 3.46M | 1.19M | 0.28M | 0.10M | 1.60M | 1.10M | 0.90M | 0.73M | 2.80M | 1.96M | 0.41M | 0.81M | 4.31M | 1.34M | 0.53M | ||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | |||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| Change in Cash | -19.54M | -4.29M | -60.78M | -16.36M | 45.64M | 0.16M | 76.78M | 1.72M | -2.08M | 1.47M | -12.86M | 14.89M | -43.46M | -21.81M | 146.83M | -173.34M | -18.15M | 0.83M | 74.44M | -45.66M | |||||||||||||
| Free Cash FlowFCF | -14.96M | -16.53M | 31.65M | -20.61M | -24.09M | -22.78M | -21.90M | -22.26M | -17.64M | -20.88M | -24.58M | -17.52M | -21.72M | -23.23M | 131.68M | -25.58M | -30.50M | -30.69M | -60.94M | -58.56M | |||||||||||||
| Net Cash FlowNCF | -19.54M | -4.29M | -60.78M | -16.36M | 45.64M | 0.16M | 76.78M | 1.72M | -2.08M | 1.47M | -12.86M | 14.89M | -43.46M | -21.81M | 146.83M | -173.34M | -18.15M | 0.83M | 74.44M | -45.66M |